Hormone therapy may shield menopausal hearts and brains — a trial puts it to the test

NCT ID NCT07732452

First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time

Summary

This trial explores whether starting transdermal estradiol (a skin gel or patch) soon after menopause can protect the heart and brain in women who have hot flashes and at least one cardiovascular risk factor. One hundred women will be randomly assigned to receive the hormone therapy or to avoid it for at least three months. Researchers will measure changes in heart muscle, blood vessels, and cognitive function over one year to see if hormone therapy might reduce early signs of cardiovascular disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
transdermal estradiol (skin gel or patch)
What this could lead to
If this approach works, it could point toward a way to reduce cardiovascular risk in menopausal women using hormone therapy.
What could go wrong
This is a small feasibility study, not designed to prove effectiveness. Hormone therapy carries known risks, including blood clots and breast cancer, which must be weighed carefully.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIAC REMODELING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.